Morphine withdrawal sensitizes mice to lipopolysaccharide: elevated TNF-alpha and nitric oxide with decreased IL-12
Related Experiment Video
Updated: Aug 17, 2026

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
Published on: July 29, 2014
Pu Feng1, Joseph J Meissler, Martin W Adler
1Center for Substance Abuse Research, Temple University School of Medicine, Philadelphia, PA 19140, USA.
Abstract:
Mice made dependent on morphine using slow-release morphine pellets for 96 h were withdrawn by removal of pellets, followed by a sublethal dose of LPS 24 h later. These animals exhibited 100% lethality. Animals withdrawn from placebo pellets receiving LPS all survived, as did morphine-withdrawn mice receiving saline. Morphine-withdrawn LPS-treated animals had elevated serum TNF-alpha and nitric oxide levels, and depressed IL-12 levels compared to controls. Anti-TNF-alpha antibody given prior to LPS challenge afforded significant protection to morphine-withdrawn animals. These studies show that morphine withdrawal sensitizes to LPS lethality via increased production of TNF-alpha.
Insights
Morphine withdrawal dramatically increases sepsis (LPS) lethality in mice. This heightened mortality is linked to elevated tumor necrosis factor-alpha (TNF-alpha) and nitric oxide, suggesting TNF-alpha inhibition as a protective strategy.
Area of Science:
- Immunology
- Pharmacology
- Toxicology
Background:
- Opioid dependence is a significant public health issue.
- Opioid withdrawal can trigger complex physiological changes.
- Sepsis, often caused by bacterial lipopolysaccharide (LPS), is a life-threatening condition.
Purpose of the Study:
- To investigate the impact of morphine withdrawal on susceptibility to lipopolysaccharide (LPS)-induced lethality.
- To elucidate the immunological mechanisms underlying this heightened susceptibility.
Main Methods:
- Morphine dependence was induced in mice using slow-release pellets over 96 hours.
- Animals were withdrawn from morphine or placebo, followed by administration of LPS or saline.
- Serum levels of TNF-alpha, nitric oxide, and IL-12 were measured.
- The effect of anti-TNF-alpha antibody treatment was assessed.
Main Results:
- Morphine-withdrawn mice challenged with LPS exhibited 100% mortality.
- Control groups (placebo withdrawal + LPS, morphine withdrawal + saline) survived.
- LPS-treated, morphine-withdrawn mice showed elevated serum TNF-alpha and nitric oxide, and reduced IL-12.
- Anti-TNF-alpha antibody administration significantly protected morphine-withdrawn mice from LPS lethality.
Conclusions:
- Morphine withdrawal sensitizes mice to LPS-induced lethality.
- Elevated TNF-alpha production during morphine withdrawal is a key mediator of this sensitization.
- Targeting TNF-alpha may offer a therapeutic approach to mitigate sepsis mortality in opioid-dependent individuals undergoing withdrawal.
More Related Videos
09:54Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence
Published on: March 8, 2020
08:16Partial Sciatic Nerve Ligation: A Mouse Model of Chronic Neuropathic Pain to Study the Antinociceptive Effect of Novel Therapies
Published on: October 6, 2022